106 related articles for article (PubMed ID: 19732438)
1. No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer.
Goode EL; Szabo C; Prokunina-Olsson L; Vierkant RA; Fredericksen ZS; Collins FS; White KL; Schmidt M; Fridley BL; Couch FJ
BMC Cancer; 2009 Sep; 9():312. PubMed ID: 19732438
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study.
Burwinkel B; Shanmugam KS; Hemminki K; Meindl A; Schmutzler RK; Sutter C; Wappenschmidt B; Kiechle M; Bartram CR; Frank B
BMC Cancer; 2006 Nov; 6():268. PubMed ID: 17109766
[TBL] [Abstract][Full Text] [Related]
3. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population.
González-Sánchez JL; Martínez-Larrad MT; Zabena C; Pérez-Barba M; Serrano-Ríos M
Diabetologia; 2008 Nov; 51(11):1993-7. PubMed ID: 18712344
[TBL] [Abstract][Full Text] [Related]
4. Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk.
Hazra A; Fuchs CS; Chan AT; Giovannucci EL; Hunter DJ
Cancer Causes Control; 2008 Nov; 19(9):975-80. PubMed ID: 18478343
[TBL] [Abstract][Full Text] [Related]
5. Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population.
Alsmadi O; Al-Rubeaan K; Mohamed G; Alkayal F; Al-Saud H; Al-Saud NA; Al-Daghri N; Mohammad S; Meyer BF
BMC Med Genet; 2008 Jul; 9():72. PubMed ID: 18655717
[TBL] [Abstract][Full Text] [Related]
6. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
Wang J; Kuusisto J; Vänttinen M; Kuulasmaa T; Lindström J; Tuomilehto J; Uusitupa M; Laakso M
Diabetologia; 2007 Jun; 50(6):1192-200. PubMed ID: 17437080
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study.
Agalliu I; Suuriniemi M; Prokunina-Olsson L; Johanneson B; Collins FS; Stanford JL; Ostrander EA
Prostate; 2008 May; 68(7):740-7. PubMed ID: 18302196
[TBL] [Abstract][Full Text] [Related]
8. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes.
Haupt A; Thamer C; Heni M; Ketterer C; Machann J; Schick F; Machicao F; Stefan N; Claussen CD; Häring HU; Fritsche A; Staiger H
Diabetes; 2010 Mar; 59(3):747-50. PubMed ID: 20028944
[TBL] [Abstract][Full Text] [Related]
9. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample.
Scott LJ; Bonnycastle LL; Willer CJ; Sprau AG; Jackson AU; Narisu N; Duren WL; Chines PS; Stringham HM; Erdos MR; Valle TT; Tuomilehto J; Bergman RN; Mohlke KL; Collins FS; Boehnke M
Diabetes; 2006 Sep; 55(9):2649-53. PubMed ID: 16936217
[TBL] [Abstract][Full Text] [Related]
10. Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population.
Rees SD; Bellary S; Britten AC; O'Hare JP; Kumar S; Barnett AH; Kelly MA
BMC Med Genet; 2008 Feb; 9():8. PubMed ID: 18291022
[TBL] [Abstract][Full Text] [Related]
11. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk.
Sanghera DK; Ortega L; Han S; Singh J; Ralhan SK; Wander GS; Mehra NK; Mulvihill JJ; Ferrell RE; Nath SK; Kamboh MI
BMC Med Genet; 2008 Jul; 9():59. PubMed ID: 18598350
[TBL] [Abstract][Full Text] [Related]
12. Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men.
Dahlgren A; Zethelius B; Jensevik K; Syvänen AC; Berne C
Diabetologia; 2007 Sep; 50(9):1852. PubMed ID: 17618413
[TBL] [Abstract][Full Text] [Related]
13. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.
Chang YC; Chang TJ; Jiang YD; Kuo SS; Lee KC; Chiu KC; Chuang LM
Diabetes; 2007 Oct; 56(10):2631-7. PubMed ID: 17579206
[TBL] [Abstract][Full Text] [Related]
14. Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects.
Miyake K; Horikawa Y; Hara K; Yasuda K; Osawa H; Furuta H; Hirota Y; Yamagata K; Hinokio Y; Oka Y; Iwasaki N; Iwamoto Y; Yamada Y; Seino Y; Maegawa H; Kashiwagi A; Yamamoto K; Tokunaga K; Takeda J; Makino H; Nanjo K; Kadowaki T; Kasuga M
J Hum Genet; 2008; 53(2):174-180. PubMed ID: 18097733
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
[TBL] [Abstract][Full Text] [Related]
16. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels.
Kimber CH; Doney AS; Pearson ER; McCarthy MI; Hattersley AT; Leese GP; Morris AD; Palmer CN
Diabetologia; 2007 Jun; 50(6):1186-91. PubMed ID: 17429603
[TBL] [Abstract][Full Text] [Related]
17. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort.
van Vliet-Ostaptchouk JV; Shiri-Sverdlov R; Zhernakova A; Strengman E; van Haeften TW; Hofker MH; Wijmenga C
Diabetologia; 2007 Jan; 50(1):59-62. PubMed ID: 17031610
[TBL] [Abstract][Full Text] [Related]
18. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population.
Horikoshi M; Hara K; Ito C; Nagai R; Froguel P; Kadowaki T
Diabetologia; 2007 Apr; 50(4):747-51. PubMed ID: 17245589
[TBL] [Abstract][Full Text] [Related]
19. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
Jin T; Liu L
Mol Endocrinol; 2008 Nov; 22(11):2383-92. PubMed ID: 18599616
[TBL] [Abstract][Full Text] [Related]
20. Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
Pearson ER; Donnelly LA; Kimber C; Whitley A; Doney AS; McCarthy MI; Hattersley AT; Morris AD; Palmer CN
Diabetes; 2007 Aug; 56(8):2178-82. PubMed ID: 17519421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
